Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Dehydration, Dizziness, Encephalitis, Enteral nutrition, Fatigue
Clinical narrative: gastroparesis/chronic abdominal pain/nausea/vomiting/constipation/extreme weight loss; dehydration; constellation of adverse symptoms, complications, injuries, and other adverse events; autoimmune injuries; dysautonomia (POTS)/headaches/increased heart rate/nausea/vomiting/constipation/dizziness/fatigue; fibromyalgia/body aches/trigger-point pain; encephalitis/chronic headaches/ataxia/neurological injuries; Information has been received from a lawyer regarding a case in litigation, concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions, and concomitant medications were not provided. On 02-JAN-2018 (when she was 11-years old), the pt was inoculated with the first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injection as prevention of cervical cancer (dose, route of administration, anatomical location, lot number, and expiration date were not provided). Consequently, on an unknown date she received a second dose of the vaccine. Also, on an unknown date, immediately after her second vaccination, the pt experienced severe injuries. She was seen by multiple physicians and specialists for her complaints which included: chronic abdominal pain, headaches, body aches, trigger-point pain, increased heart-rate, nausea, vomiting, constipation, dizziness, fatigue, dehydration, and extreme weight loss. As a result of her post- Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, the pt has been unable to engage in activities that a normal young person would enjoy. She was initially admitted to the hospital for emergency medical treatments multiple times, necessitating hydration and nutrition through a nasojejunal tube for months. Upon discharge, she needed to complete physical therapy and rehabilitation at a medical center. While struggling with her severe health issues stemming from the Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injections, the pt had to withdraw from school and missed some critical social development years. As recent as October 2022, the pt's injuries flared up, causing her to be admitted into the hospital for nasojejunal tube-feeding again. Based upon her chronic and severe post-vaccination symptoms, the pt has been diagnosed with various medical conditions, including but not limited to, encephalitis, ataxia, dysautonomia (POTS), fibromyalgia, chronic headaches, and gastroparesis, requiring continuing medical attention and medications. In addition, the pt contended that her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injections caused her to develop serious and debilitating autoimmune, autonomic, and neurological injuries, including but not limited to encephalitis, ataxia, dysautonomia (POTS), fibromyalgia, chronic headaches, and gastroparesis, as well as a constellation of adverse events symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) or otherwise linked to her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced autoimmune disorder. The outcome of the adverse events was unknown. Moreover it was considered the events to be related to Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL).  The events were considered as disabling, since they resulted in a substantial disruption of the pt's school education.  Upon internal review the events autoimmune disorder, encephalitis, and impaired gastric emptying were determined to be medically significant.